Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

HKG/9969 stock hub

HKG/9969 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

HKG/9969is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

27.4B

Hong Kong Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

HKG/9969

In the news

Latest news · HKG/9969

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E93.1

P25 11.7P50 18.9P75 41.4

Trailing P/E27.4

P25 10.7P50 17.9P75 38.5

ROE10.4

P25 -14.7P50 2P75 9.4

ROIC26.3

P25 -10.4P50 1.9P75 10.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All HKG/9969 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

200

Groups with data

Currency

CNY

Showing 200 of 200 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Cayman Islands
Country code	HK
Employees	1,176
Employees Change	87%
Employees Change Percent	7.99
Enterprise value	HKD 21.1B
Exchange	Hong Kong Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Biotechnology
Isin	KYG4783B1032
Last refreshed	2026-05-10
Market cap	HKD 27.4B
Price	HKD 13.51
Price currency	HKD
Rev Per Employee	2,437,908.42x
Sector	Healthcare
Sic	2836
Symbol	hkg/9969
Website	https://www.innocarepharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.03%
EV Earnings	25.45x
EV/EBIT	33.97x
EV/EBITDA	28.27x
EV/FCF	-426.93x
EV/Sales	7.37x
FCF yield	-0.18%
Forward P/E	93.14x
P/B ratio	3.28x
P/E ratio	27.38x
P/S ratio	9.57x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	21.69%
EBITDA Margin	24.88%
Gross margin	91.36%
Gross Profit	HKD 2.6B
Gross Profit Growth	114.44%
Gross Profit Growth Q	34.97%
Gross Profit Growth3 Y	62.4%
Gross Profit Growth5 Y	117.9%
Net Income	HKD 830.1M
Net Income Growth Q	488.93%
Net Income Growth Quarters	2%
Net Income Growth Years	3%
Pretax Margin	29.51%
Profit Margin	28.95%
Profit Per Employee	HKD 705,891
Profitable Years	1
ROA	3.45
Roa5y	-2.42
ROCE	6.13
ROE	10.36
Roe5y	-4.25
ROIC	26.31
Roic5y	-85.01

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	41.5%
Cagr3y	14.58%
Cagr5y	-11.44%
EPS Growth Q	500
EPS Growth Quarters	2
EPS Growth Years	3
OCF Growth Q	-92.53%
Revenue Growth	105.92x
Revenue Growth Q	38.65x
Revenue Growth Quarters	8x
Revenue Growth Years	3x
Revenue Growth3 Y	53.63x
Revenue Growth5 Y	117.5x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	HKD 0.25
Assets	HKD 11.8B
Cash	HKD 8.1B
Current Assets	HKD 9.4B
Current Liabilities	HKD 1.7B
Debt	HKD 1.7B
Debt EBITDA	HKD 2.33
Debt Equity	HKD 0.21
Debt FCF	HKD -35.19
Equity	HKD 8.4B
Interest Coverage	10.11
Liabilities	HKD 3.4B
Long Term Assets	HKD 2.4B
Long Term Liabilities	HKD 1.8B
Net Cash	HKD 6.3B
Net Cash By Market Cap	HKD 23.04
Net Cash Growth	1.76%
Net Debt EBITDA	HKD -8.86
Net Debt Equity	HKD -0.76
Tangible Book Value	HKD 8.1B
Tangible Book Value Per Share	HKD 4.57
WACC	6

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	5.65
Inventory Turnover	1.61
Net Working Capital	HKD 205M
Quick ratio	5.23
Working Capital	HKD 7.7B
Working Capital Turnover	HKD 0.42

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.97%
Payout Ratio	4.61%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	41.47%
200-day SMA	14.78
3Y total return	50.45%
50-day SMA	13.31
50-day SMA vs 200-day SMA	50under200
5Y total return	-45.52%
All Time High	32.05
All Time High Change	-57.85%
All Time High Date	2021-07-19
All Time Low	4.03
All Time Low Change	235.24%
All Time Low Date	2024-04-19
ATR	0.68
Beta	0.35
Beta1y	1.2
Beta2y	0.92
Ch YTD	9.84
High	14.05
High52	20.62
High52 Date	2025-08-19
High52ch	-34.48%
Low	13.41
Low52	8.86
Low52 Date	2025-05-12
Low52ch	52.48%
Ma50ch	1.54%
Price vs 200-day SMA	-8.58%
RSI	44.73
RSI Monthly	55.94
RSI Weekly	49.66
Sharpe ratio	0.78x
Sortino ratio	1.34
Total Return	0.97%
Tr YTD	9.84
Tr1m	-12.95%
Tr1w	-1.46%
Tr3m	5.22%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	HKD 622M
Operating margin	21.69

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,126,814,760%
Net Borrowing	260,389,230.8
Shares Insiders	20.72%
Shares Institutions	29.97%
Shares Out	1,695,928,424
Shares Qo Q	-8.7%
Shares Yo Y	-0.97%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	HKD -128.6M
Average Volume	7,574,896.6x
Bv Per Share	4.73
CAPEX	HKD -85.4M
Ch1m	-12.95
Ch1w	-1.46
Ch1y	41.47
Ch3m	5.22
Ch3y	50.45
Ch5y	-45.52
Ch6m	-3.5
Change	-3.02%
Change From Open	-2.95
Close	13.93
Days Gap	-0.07
Depreciation Amortization	92,619,380.2
Dollar Volume	79,390,069.4
Earnings Date	2026-04-24
EBIT	HKD 622M
EBITDA	HKD 713.4M
EPS	HKD 0.49
F Score	6
FCF	HKD -49.5M
FCF EV Yield	-0.23x
FCF Per Share	HKD -0.03
Financing CF	231,051,389
Fiscal Year End	December
Founded	2,015
Goodwill	3,598,296
Graham Number	7.24908
Graham Upside	-46.34
Income Tax	HKD 13.7M
Investing CF	-945,794,693
Is Primary Listing	1
Last Earnings Date	2026-04-24
Last Report Date	2026-03-31
Ma150	13.72
Ma150ch	-1.56%
Ma20	14.48
Ma20ch	-6.69%
Net CF	-816,689,970
Next Earnings Date	2026-05-11
Open	13.92
P OCF Ratio	763.6
Position In Range	15.62
Ppne	840,028,627.4
Price Date	2026-05-08
Price EBITDA	HKD 38.45
Ptbv Ratio	3.4
Relative Volume	0.77x
Revenue	2,866,980,300x
SBC By Revenue	2.76x
Share Based Comp	79,117,921
Tax By Revenue	0.48x
Tax Rate	1.62%
Tr6m	-3.5%
Volume	5,876,393

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does HKG/9969 pay a dividend?

Capital-return profile for this ticker.

Performance

HKG/9969 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns HKG/9969?

Insider, institutional, and short-interest positioning.

Institutional ownership

+30.0%

Share of float held by funds and institutions

Insider ownership

+20.7%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-1.0%

Negative means the company is buying back shares.

Technical

HKG/9969 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

44.7

Neutral momentum band

Price vs 200-day MA

-8.6%

50/200-day relationship not available

Beta (5Y)

0.35

Less volatile than the market

Sharpe ratio

0.78

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About HKG/9969

Hub-level FAQ points readers to the deeper analysis pages.

What is the current hkg/9969 stock rating?

hkg/9969 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full hkg/9969 analysis?

The full report lives at /stocks/hkg/9969/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for hkg/9969?

The latest report frames hkg/9969 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the hkg/9969 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.